Home/Companies/Biotech/F2G

F2G

Biotech·

United Kingdom·Active·7yr hold

Entry

2019

Hold

7yr

Status

Active

Who owns F2G?

F2G is a British Biotech company, currently owned by Sofinnova Partners since 2019 and Sunstone Life Science Ventures.

Hand-verified · updated 2026-09-30

Open JSON · CC-BY

Most recent investor

Sofinnova Partners

Sofinnova Crossover Fund I · 2018 · VC

2 ownership periods · full history below

Key facts

HQUnited Kingdom

SectorBiotech

Websitef2g.com

Ownership history

2 ownership periods · co-invest detected

Active

Co-held by Sunstone Life Science Ventures and Sofinnova Partners since 2010.

Co-invest · 2 holders · 2010 · present

Sunstone Life Science VenturesActive

2010 · present(16yr) · Sunstone Life Science Ventures III · 2007 · VC

Sofinnova PartnersActive

2019 · present(7yr) · Sofinnova Crossover Fund I · 2018 · VC

More from Sofinnova Crossover Fund I

Other portfolio companies in the same fund.

Sphere Bio (formerly Sphere Fluidics)

More PE-backed in Biotech

Comparable biotech deals from other GPs.

Abbisko Healthcare

Active

The Carlyle GroupChina

Adagene

Active

General AtlanticChina

Advanced Cell Diagnostics

Questions

Who owns F2G?

F2G is currently owned by Sofinnova Partners and Sunstone Life Science Ventures, through Sofinnova Crossover Fund I, since 2019.

When did Sofinnova Partners and 1 other acquire F2G?

Sofinnova Partners and 1 other acquired F2G in 2019.

Who has owned F2G over time?

F2G has been through 2 private-equity ownership periods: Sunstone Life Science Ventures · via Sunstone Life Science Ventures III · since 2010; Sofinnova Partners · via Sofinnova Crossover Fund I · since 2019.

Look up another firm or company

Data refreshed weekly · Sourced from public filings · Report an issue